Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis.

about

Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q42371659

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Efficacy and safety of pramlin ...... atic review and meta-analysis.

@en

Efficacy and safety of pramlin ...... atic review and meta-analysis.

@nl

type

Item

label

Efficacy and safety of pramlin ...... atic review and meta-analysis.

@en

Efficacy and safety of pramlin ...... atic review and meta-analysis.

@nl

prefLabel

Efficacy and safety of pramlin ...... atic review and meta-analysis.

@en

Efficacy and safety of pramlin ...... atic review and meta-analysis.

@nl

P1476

Efficacy and safety of pramlin ...... atic review and meta-analysis.

@en

P2093

Dan Zhou

http://www.w3.org/2001/XMLSchema#string

Hai-Lu Zhao

http://www.w3.org/2001/XMLSchema#string

Wei Ling

http://www.w3.org/2001/XMLSchema#string

Xiao-Xi Zhang

http://www.w3.org/2001/XMLSchema#string

Yan-Hong Pan

http://www.w3.org/2001/XMLSchema#string

Yan-Mei Huang

http://www.w3.org/2001/XMLSchema#string

Yin-Ling Chen

http://www.w3.org/2001/XMLSchema#string

Yong-Chao Qiao

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Neuroendocrine hormone amylin in diabetes

Measuring inconsistency in meta-analyses

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Efficacy and harms of the hypoglycemic agent pramlintide in diabetes mellitus

Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control.

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial.

Amyloidogenesis of the amylin analogue pramlintide.

Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone.

Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes

P304

66504-66515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.16008

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29029531

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

5630431

http://www.w3.org/2001/XMLSchema#string